Search clinical trials for: Trastuzumab emtansine [Kadcyla]
Total 1172 results
-
Byondis B.V.CompletedSolid TumorsNetherlands, Belgium, United Kingdom, Spain
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Zhejiang Cancer HospitalRecruiting
-
Northwell HealthTerminated
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedColorectal NeoplasmUnited States, Spain, Japan, Italy, United Kingdom
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaboratorsUnknownColorectal CancerChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Puma Biotechnology, Inc.CompletedAdvanced Breast CancerUnited States, Switzerland, China, France
-
Centre Antoine LacassagneCompleted
-
MedSIRDaiichi SankyoNot yet recruitingBreast Cancer | Metastatic Breast Cancer
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian CancerUnited States, Korea, Republic of, France, Germany, Spain, Italy, Canada, Russian Federation, United Kingdom, Turkey, Australia, Czechia, Switzerland
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.; Translational Breast Cancer Research ConsortiumActive, not recruiting
-
Shengjing HospitalNot yet recruiting
-
PfizerCompletedCarcinoma, Metastatic BreastUnited States
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Fudan UniversityRecruiting
-
University of ArizonaPfizerCompletedBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | Recurrent Breast Cancer | HER2 Positive Breast Carcinoma | Breast Cancer StageUnited States
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingPosterior Fossa Ependymoma (PFEPN)United States
-
Institut Paoli-CalmettesInnate PharmaRecruitingMetastatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer | Oesophageal Cancer | Metastatic Ovary CancerFrance
-
Hospices Civils de LyonNot yet recruiting
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknown
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent... and other conditionsUnited States
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Institut du Cancer de Montpellier - Val d'AurelleCompleted
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...Completed
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
Genentech, Inc.Approved for marketing
-
Veana TherapeuticsUniversity of WashingtonRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast CarcinomaUnited States
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina
-
AstraZenecaHospital Israelita Albert EinsteinActive, not recruiting
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Italy, France, Japan, Taiwan, Netherlands, Australia, Canada
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Centre Oscar LambretTerminatedBreast Cancer | Metastasis | Sur-expressing Her2-neuFrance